Article,
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
Affiliations
- [1] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplantat Serv, New York, NY 10065 USA [NORA names: United States; America, North; OECD];
- [2] Herlev Hosp, Natl Ctr Canc Immune Therapy, Dept Oncol, DK-2730 Herlev, Denmark [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];
- [3] Copenhagen Univ Hosp, Dept Immunol & Microbiol, DK-2730 Herlev, Denmark [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
- [4] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA [NORA names: United States; America, North; OECD];
- [5] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA [NORA names: United States; America, North; OECD];
(... more)
Abstract
Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.